It has now come to light that Takeda Pharmaceuticals knew about the cancer risks associated with the ingestion of Actos, a drug they developed to treat type 2 diabetes. However,...
Read More
The first Actos lawsuit has gone to trial in a California Superior Court in Los Angeles, known as Cooper v. Takeda Pharmaceuticals America Inc. Cooper v. Takeda is being heard…
The second Actos bladder cancer lawsuit is currently on trial in the Circuirt Court for the City of Baltimore. The plaintiffs in the case, the family of Diep An, a…
Closing arguments concluded before Memorial Day weekend in an Actos bladder cancer lawsuit in a Nevada state court in Las Vegas. The plaintiffs in the case filed their lawsuit targeted…
Research demonstrates a strong connection between the development of bladder cancer and the use of Actos, a drug prescribed to patients with diabetes. Actos is known generically as pioglitazone, and…
Testimony provided in late March by a urologist in an Actos trial taking place in a Los Angeles court presented an expert’s opinion about the link between Actos and bladder…
The manufacturer of the diabetes drug Actos, a drug that is tied up in mounting complaints and lawsuits citing the development of bladder cancer, has received U.S. Food and Drug…
In 2003, Takeda Pharmaceuticals Inc. expressed concerns about whether Actos users could develop cancer. These reservations on the part of the Japanese pharmaceutical company came to light in court documents…
Takeda Pharmaceuticals, the Japanese pharmaceutical giant responsible for the development and marketing of the diabetes drug Actos, concealed the association between Actos and bladder cancer, a jury was recently told…
Published November 29, 2012 by PR Web St. Louis, Missouri (PRWEB) November 29, 2012 November is American Diabetes Month and the pharmaceutical product liability lawyers at Carey Danis & Lowe…